RAC 3.31% $1.61 race oncology ltd

RAC - Charts & Price Action, page-18233

  1. 1,447 Posts.
    lightbulb Created with Sketch. 486
    It failed because the data from the 50 clinical trials wasn't complete or compelling enough for FDA approval?

    Or did noone want to prescribe RC110 even if it got approval? Better treatments available?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.